<DOC>
	<DOCNO>NCT02853526</DOCNO>
	<brief_summary>To date , treatment strategy patient accord American Association Study Liver Disease ( AASLD ) practice guideline Baveno V consensus . Thus , aim compare safety efficacy TIPS conservative treatment ( non-selective beta blocker , endoscopic therapy and/or anticoagulation ) patient PVT CPTV .</brief_summary>
	<brief_title>TIPS Variceal Rebleeding Cirrhotic Patients With Occlusive Portal Vein Thrombosis CTPV</brief_title>
	<detailed_description>The incidence portal vein thrombosis ( PVT ) 16 % cirrhotic patient . Chronic PVT often cause two main undesirable consequence : symptomatic portal hypertension ( variceal bleeding ascites ) cavernous transformation portal vein ( CPTV ) . The former could lead death latter increase difficulty transjugular intrahepatic portosystemic shunt ( TIPS ) treatment , consider main effective treatment symptomatic portal hypertension . Some patient CPTV variceal bleed receive conservative treatment ( non-selective beta blocker , endoscopic therapy and/or anticoagulation ) . With advance technology , modify TIPS procedure could significantly improve operation success rate patient CPTV . To date , difference safety efficacy TIPS conservative treatment ( non-selective beta blocker , endoscopic therapy and/or anticoagulation ) patient PVT CPTV still unclear .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Esophageal Gastric Varices</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>All patient diagnosis portal vein thrombosis cavernous transformation portal vein portal hypertension contrast enhance CT MRI . History variceal bleeding . Liver cirrhosis . Neutrophilous counts≥ 1.5×109/L , Platelet count ≥ 50 × 109/L , Hemoglobin≥ 85g/L . Albumin ≥2.8 g/dL , total bilirubin &lt; 51.3 umol/L ; alanine aminotransferase ( ALT ) aspartate transaminase（AST） &lt; 5 time upper limit . PT ( Prothrombin time ) INR ( international normalize ratio ) &lt; 1.7 . Thrombosis involve superior mesenteric vein , splenic vein , whole portal vein system . Not suitable TIPS ( judge principal investigator ) . Company malignant tumor liver organ . Patients know severe dysfunction heart , lung , brain kidney . Active bleeding . Not eligible anticoagulation therapy , nonselective beta blocker endoscopic therapy . Uncontrolled infection . Pregnancy breastfeed . HIV infection .</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>